The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mebius, R. E.
Right arrow Articles by Randall, T. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mebius, R. E.
Right arrow Articles by Randall, T. D.
The Journal of Immunology, 1998, 161: 3836-3843.
Copyright © 1998 by The American Association of Immunologists

Transfer of Primitive Stem/Progenitor Bone Marrow Cells from LT{alpha}-/- Donors to Wild-Type Hosts: Implications for the Generation of Architectural Events in Lymphoid B Cell Domains1

Reina E. Mebius2,3,*, Silvy van Tuijl*, Irving L. Weissman{dagger},{ddagger} and Troy D. Randall2

* Department of Cell Biology and Immunology, Faculty of Medicine, Vrije Universiteit, Amsterdam, The Netherlands; Departments of {dagger} Pathology and {ddagger} Developmental Biology, Stanford University School of Medicine, Stanford, CA 94305; and § Trudeau Institute, Saranac Lake, NY 12983


    Abstract
 Top
 Abstract
 Introduction
 Materials and Methods
 Results and Discussion
 References
 
To analyze whether the phenotypic abnormalities observed in lymphotoxin-{alpha}-/- (LT{alpha}-/-) mice are intrinsic to the hemolymphoid system itself or dependent on stromal elements, wild-type (WT) mice were reconstituted with bone marrow (BM) cells enriched for hemopoietic stem cells from LT{alpha}-/- animals. WT mice reconstituted with LT{alpha}-/-c-kit+Lin-Sca-1+ BM cells do not maintain follicular dendritic cell (FDC) networks and do not form primary follicles, while clear segregation of B and T cells could be observed. Furthermore, IgM+IgD- B cells, MOMA-1 (anti-metallophilic macrophages), ERTR-9 (anti-marginal zone macrophages), and MECA-367 (anti-MAdCAM-1) were all absent from the splenic marginal zone. Surprisingly, however, the expression of MOMA-1, ERTR-9, and MAdCAM-1 was normal in the lymph nodes of mice reconstituted with LT{alpha}-/- cells. In addition, peanut agglutinin-positive germinal centers were observed in both the spleen and mesenteric lymph nodes, although in the absence of detectable FDC. Furthermore, in animals reconstituted with a mixture of LT{alpha}-/- and WT c-kit+Lin-Sca-1+, GC contained either predominantly LT{alpha}-/- B cells or WT B cells. These results suggest that although the formation of primary follicles, FDC networks, and the splenic marginal zone are all dependent on hemopoietically derived LT{alpha}, germinal center formation and the expression of MAdCAM-1, MOMA-1, and ERTR-9 in lymph nodes are not. Our results also suggest that the disturbed B-T cell separation in LT{alpha}-/- mice is unrelated to defects in the marginal zone.


    Introduction
 Top
 Abstract
 Introduction
 Materials and Methods
 Results and Discussion
 References
 
Members of the TNF superfamily of regulatory molecules TNF-{alpha} and lymphotoxin-{alpha} (LT{alpha})4 are involved in both inflammatory and immune responses (1). Both TNF-{alpha} and LT{alpha} can exist as soluble homotrimers and can bind to both TNFR-I (p55) and TNFR-II (p75) (2, 3, 4). In addition, LT{alpha} can exist as a membrane-bound heterotrimer with LTß, which provides the transmembrane domain (5). This LT{alpha}1ß2 complex can be specifically recognized by the LTßR, but not TNFR-I or TNFR-II (6). Thus, TNF-{alpha} and LT{alpha} have overlapping, yet unique, signaling functions depending on which ligand/receptor combination is used.

Recently, studies in mice deficient for the TNF/LT receptors or ligands have shown that these molecules also play important roles in the development and organization of the immune system (7, 8, 9, 10). Signaling of TNF-{alpha} through the TNF receptor p55 (TNFR-I) is necessary to form primary follicles (ovoid collections of resting IgM+IgD+ (Bµ{delta}) cells with interspersed follicular dendritic cells (FDC)), germinal centers (GC) (collection of activated IgD-L-selectin- B cells, apoptotic cells, activated CD4 T cells, macrophages, and GC-type dendritic cells (DC) (11)), and a network of FDC as shown in TNF-{alpha}-/- and TNFR-I-/- mice (7, 8, 9, 10). B and T cell areas (12) still segregate in the lymphoid organs of these mice, and all peripheral lymph nodes, mesenteric lymph nodes, and Peyer’s patches are present (9, 10).

In contrast, the lymph nodes and Peyer’s patches are completely absent in LT{alpha}-deficient mice (13, 14), although rudimentary mesenteric lymph nodes can be observed in rare animals (14, 15). Furthermore, the normal T cell/B cell segregation was disrupted in the spleens of LT{alpha}-/- mice, and they were reported to be missing FDC and GC (7, 13). Part of these abnormalities are due to lack of signaling through the lymphotoxin-ß receptor (LTß-R) ligand, since blocking of this ligand during gestation results in the absence of Peyer’s patches and most of the peripheral lymph nodes, but not mesenteric lymph nodes (16, 17). Upon reconstitution of WT mice with either LT{alpha}-/- splenocytes or BM cells, normal B and T cell compartmentalization was observed, while reconstitution of LT{alpha}-/- mice with WT splenocytes or BM cells showed a lack of normal B/T cell segregation (18). In addition, in LT{alpha}-/- mice reconstituted with normal BM, GC could be observed, suggesting that the source of LT{alpha} required for GC formation is a BM-derived cell type (7).

To determine whether all defects in LT{alpha}-/- mice could be attributed to the lack of LT{alpha} expression in cells of the hemopoietic lineage, we reconstituted lethally irradiated WT mice with LT{alpha}-/- BM cells, highly enriched for hemopoietic stem cells, separated using FACS into c-kit+Lin-Sca-1+ cells (KLSC). Using a population of purified hemopoietic progenitors, not contaminated by BM-derived stromal cells or their precursors, allowed us to study the effect of the absence of LT{alpha} in hemopoietic cells only. Injection of Ly-5.1+LT{alpha}-/- cells into Ly-5.2+ WT mice permitted us to follow the progeny of LT{alpha}-/- progenitor cells at the single-cell level in situ. We also made mixed chimeras, reconstituted with KLSC from both LT{alpha}-/- and WT mice, to determine which defects observed in LT{alpha}-/- KLSC-reconstituted mice were abolished in the presence of WT hemopoietic cells and whether LT{alpha}-/- cells were at a competitive disadvantage, in particular lymphoid structures. Here we show that although LT{alpha}-/- B cells are incapable of forming discrete primary follicles, they can form GC, similar to the phenotype of the LTß-/- mice (17).


    Materials and Methods
 Top
 Abstract
 Introduction
 Materials and Methods
 Results and Discussion
 References
 
Animals

C57BL/Ka-Ly-5.2 mice were maintained in the laboratory animal colony at Stanford University School of Medicine, Stanford, CA. LT{alpha}-/- mice (backcrossed to C57BL/6 (Ly-5.1) generations F6 and F7) were kindly provided by Dr. D. Chaplin (Washington University, St. Louis, MO) via Dr. P. R. Streeter (Monsanto, St. Louis, MO). All animals were kept under routine laboratory conditions.

Antibodies

The following Abs were used to label for either FACS analysis or immunohistology: 6B2 (anti-B220); KT-31 (anti-CD3); M1/70 (anti-Mac-1); 8C5 (anti-Gr-1); NK1.1 (anti-NK cell marker; PharMingen, San Diego, CA); AL1-4A2 (anti-Ly-5.1); A20.1.7 (anti-Ly-5.2); 104 (anti-Ly-5.2; PharMingen) (mAb 6B2, KT-31, M1/70, 8C5, AL1-4A2, and A20.1.7 were affinity purified from culture supernatant from hybridoma cells with protein G-Sepharose (Pharmacia, Uppsala, Sweden) and labeled in our laboratory); FDC-M2 (anti-FDC; provided by M. Kosco); ED31 (anti-MARCO (19); provided by L. van der Laan); ERTR-9 (anti-marginal zone macrophages); MOMA-1 (anti-metallophilic macrophages) (mAb ERTR-9, and MOMA-1 were provided by G. Kraal); MECA-367 (anti-MAdCAM-1; hybridoma was provided by E. C. Butcher); b.7.6 (anti-mouse IgM) (20); 1.19 (anti-mouse IgD) (21) (mAb b.7.6 and 1.19 were provided by G. G. B. Klaus).

Isolation and injection of populations highly enriched for hemopoietic stem cells

BM was obtained by flushing femurs and tibias from C57BL/Ka-Ly-5.2 or LT{alpha}-/- (Ly-5.1) mice with PBS containing 2% calf serum. The BM suspension was filtered through nylon mesh and stained for 20 min on ice with a lineage mixture of unlabeled Abs containing M1/70 (anti-Mac-1), 8C5 (anti-Gr-1), GK1.5 (anti-CD4), 53-6.7 (anti-CD8), KT-3.1 (anti-CD3), 53-7.3 (anti-CD5), 6B2 (anti-B220), and Ter119 (anti-erythroid), and most positive cells were removed using the MACS magnetic bead system (Miltenyi Biotech, Sunnyvale, CA) as described elsewhere (22). The lineage- fraction was subsequently stained with anti-Sca-1 (E13) and anti-c-kit (3C11), and the Sca-1+c-kit+lineage- (KLS) population was sorted.

Long term reconstitution assays

C57BL/Ka-Ly-5.2 mice were lethally irradiated with 930 rads using an x-ray source operated at 200 kV, delivering 85 rads/min. Mice were irradiated in two doses, of 465 rads each, 3 to 5 h apart. Sca-1+, c-kit+, lineage- hemopoietic stem cells (1000) from either LT{alpha}-/- (Ly-5.1) (KLSC-LT{alpha}-/-) or WT (C57BL/Ka-Ly-5.2) (KLSC-WT) mice or a combination of 1000 KLSC-LT{alpha}-/- and 1000 KLSC-WT (mixed KLSC) were injected retroorbitally into irradiated hosts (C57BL/Ka-Ly-5.2). Five mice were reconstituted per group. After irradiation, mice were maintained on antibiotics present in the water (1.1 g/L neomycin sulfate and 106 U/L polymyxin B sulfate).

Analysis of reconstituted mice

For analysis of reconstitution, mice were bled from the tail and assayed for the presence of Ly-5.2+ cells of each lineage. To do so PBL were stained for lineage markers, anti-B220 to identify B cells, anti-CD3 to identify T cells, and a combination of anti-Mac-1 and anti-Gr-1 to identify myeloid cells, in combination with anti-Ly-5.2. Mice were killed to analyze spleen, lymph nodes, and Peyer’s patches by immunohistology at different time points (13–27 wk) after reconstitution.

Immunohistochemistry

Cryostat sections of spleens or lymph nodes (5 µm thick) were allowed to dry for 15 min before fixation in acetone (2 min) after which they were air dried for another 15 min (12). The sections were incubated with various anti-mouse mAbs at saturating concentrations in PBS containing 0.1% BSA (PBS/BSA) for 45 min. After thorough washing in PBS, sections were incubated with the appropriate peroxidase-labeled second step reagent (Jackson ImmunoResearch, San Francisco, CA) in PBS/BSA.

For in situ analysis of donor-derived cells in the mixed chimeras, sections were stained for Ly-5.1 or Ly-5.2, in combination with several rat anti-mouse mAb. The sections were incubated with biotin-conjugated Ly-5 and one of the rat anti-mouse mAb for 45 min at room temperature, followed by peroxidase-labeled avidin-biotin complex (DAKO, Carpinteria, CA) and alkaline phosphatase-labeled goat anti-rat Ig in the presence of 5% mouse serum (Sigma, St. Louis, MO). Peroxidase activity was visualized by staining with 3,3'-diaminobenzidine tetrahydrochloride (Sigma) at a concentration of 0.5 mg/ml, in Tris buffer (pH 7.2–7.6) containing 0.01% H2O2 for 10 min at room temperature. Alkaline phosphatase was detected using Fast Blue (Sigma), as described earlier (23). Double labelings for IgM and IgD were performed as described elsewhere (9, 24).


    Results and Discussion
 Top
 Abstract
 Introduction
 Materials and Methods
 Results and Discussion
 References
 
LT{alpha}-/- B and T cells segregate normally in WT spleens

In addition to the absence of lymph nodes and Peyer’s patches in LT{alpha}-deficient mice, there is a failure of the normal B and T cell segregation (12) in the spleen (13, 14). However, it is unclear whether this abnormality is due to an intrinsic B or T cell defect or a defect in lymphocyte development, or whether stromal cells in the spleen are lacking the necessary molecules to keep the B and T cells in place. Previous studies, in which LT{alpha}-/- splenocytes or bone marrow cells were transferred to WT recipients, suggest that the defect of proper B/T cell segregation in LT{alpha}-/- mice lies at the level of the stromal cells within the spleen (18). However, these studies were done with mixtures of cell populations (total spleen or bone marrow cells), and we therefore repeated these studies with a highly enriched precursor population isolated from the bone marrow. We reconstituted lethally irradiated C57BL/6 mice with KLSC from either LT{alpha}-/- mice or wild-type (WT) C57BL/6 mice using the congenic Ly-5 system to be able to trace the transferred cells. Hemolymphoid cells derived from the LT{alpha}-/- mice all express the Ly-5.1 allelic form of CD45 and can easily be distinguished from cells of WT mice, which express the Ly-5.2 form.

We sorted the c-kit+lineage-Sca-1+ (KLS) population of cells, which contains the most primitive hemopoietic stem cells with long term reconstituting potential (22), from the bone marrow of both LT{alpha}-/- and WT mice. The Sca-1+c-kit+lineage- BM cells were found at a similar frequency in both strains of mice, indicating that the absence of LT{alpha} had no effect on the maintenance of primitive hemopoietic progenitors. Lethally irradiated WT mice were then reconstituted with 1000 Sca-1+c-kit+lineage- cells from either LT{alpha}-/- or WT mice. In addition, five mice were also reconstituted with a mix of KLSC from both LT{alpha}-/- and WT mice, to test for any competitive defects in the cells derived from the LT{alpha}-/- KLSC.

At different times after reconstitution, the mice were analyzed by FACS analysis of peripheral blood for the percentage of LT{alpha}-/--derived cells, as well as by immunohistochemistry for their cellular distribution in situ. At all time points, the reconstituted mice had the expected percentages of LT{alpha}-/- and WT cells in peripheral blood. Thus, mice reconstituted with LT{alpha}-/- KLSC had >90% LT{alpha}-/--derived PBLs in all lineages, while mice reconstituted with mixed KLSC had between 30 and 60% LT{alpha}-/--derived PBLs in all lineages. As expected, mice reconstituted with WT KLSC had 100% WT PBLs. Furthermore, the degree of reconstitution was stable throughout a period of 27 wk, when the last animals were killed. Thus, the hemopoietic compartment of the bone marrow appeared normal in LT{alpha}-/- animals, and we did not observe any selective defects in the production of circulating T, B, or myeloid cells even when LT{alpha}-/- and WT cells were in a competitive situation (not shown).

At 13, 23, and 27 wk after reconstitution, tissues were analyzed by immunohistochemistry. Labelings for B220 and CD3 were performed to determine whether distinct B and T cell areas could be found. In mice reconstituted with WT cells, B and T cell areas were segregated normally, as expected (Fig. 1Go, A, C, and E). In mice reconstituted with KLSC derived from LT{alpha}-/- mice, distinct B and T cell areas could be observed in both spleen and lymph nodes (Fig. 1Go, B, D, and F), although the B cells tended to be organized in a ring around the T cell area rather than in discrete follicles. Therefore, although well-defined B and T cell areas are absent in LT{alpha}-/- mice, LT{alpha}-/--deficient B and T cells can clearly find their final destination in a WT host. Our results suggest that the defect in initial formation of segregated T and B cells areas in LT{alpha}-/- mice is not a consequence of the failure of hemolymphoid cells and that either these domains, once established in WT mice, are stable in the absence of local LT{alpha} expression, or that radioresistant cells in the spleen are producing LT{alpha}/ß, necessary for the organization of B-T cell compartments. The recent observation that injection of LTß-R-Ig chimeras in adult WT mice causes a loss of B cell follicles and a disappearance of the B and T cell compartments suggests that radioresistant cells in the spleen are producing LTß-R ligands continuously (25). This production of LTß-R ligands is apparently not sufficient for the organization of B cells into follicles.



View larger version (134K):
[in this window]
[in a new window]
 
FIGURE 1. Immunohistochemical labeling of B cells and T cells in the spleen (AD) and lymph nodes (LN) (E, F). Serial spleen sections were stained with either the anti-B220 mAb 6B2 (A, B, E, F) to show distinct B cell areas or the anti-CD3{epsilon} mAb KT-3 (C, D). Spleen and lymph node sections are from WT mice reconstituted with WT KLSC (spleen: A, C; LN: E), or WT mice reconstituted with LT{alpha}-/- KLSC (spleen: B, D; LN: F) at 23 wk after reconstitution. Stainings are representative for all other time points studied.

 
Mice reconstituted with LT{alpha}-/- KLSC have defects in the splenic marginal zone but not in the lymph node subcapsular sinus

Cell expressing the macrophage-specific Ag MOMA-1 have been reported to be missing in the marginal zone of the spleen of the LT{alpha}-/- mice (7). In addition, MAdCAM-1 expression could not be observed on the splenic sinus lining cells of either LT{alpha} and TNF-{alpha} doubly deficient mice (26) or LTß-R-Ig-infused mice (16). Here we found that although ERTR-9+, MOMA-1+, and MAdCAM-1+ (MECA-367) cells could be easily observed in mice reconstituted with WT KLSC (Fig. 2Go, A–C), neither MOMA-1+ metallophilic macrophages nor ERTR-9+ marginal zone macrophages could be detected in the spleens of animals reconstituted with LT{alpha}-/- cells (Fig. 2Go, D–E). Furthermore, there was a complete lack of MAdCAM-1 expression on the marginal sinus lining cells (as well as in germinal centers) in these animals compared with WT controls (Fig. 2GoF). When spleen sections of mice reconstituted with LT{alpha}-/- cells were stained with acid phosphatase, a diminished population of macrophages in the marginal zone could be observed, suggesting that not only were the Ags recognized by MOMA-1 and ERTR-9 absent but also the whole splenic macrophage population was significantly reduced in size (data not shown). Analysis of the peripheral and mesenteric lymph nodes of mice reconstituted with LT{alpha}-/- KLSC, however, demonstrated that the Ags ERTR-9 and MOMA-1 were expressed in these organs (Fig. 2Go, G and H). In addition, MAdCAM-1 was expressed without any abnormality on high endothelial venules in Peyer’s patches and mesenteric lymph nodes of mice reconstituted with LT{alpha}-/- cells (Fig. 2GoI). Therefore, in the spleen at least, the lack of MOMA-1, ERTR-9, and MAdCAM-1 in the marginal zone of the spleen must be caused by a lack of LT{alpha} from a BM-derived cell type. However, the LT{alpha} signal does not appear to be necessary for the presence of cells expressing MOMA-1, ERTR-9, or MAdCAM-1 in the lymph nodes. The signals that are involved in these regulatory events need to be clarified further.



View larger version (94K):
[in this window]
[in a new window]
 
FIGURE 2. Immunohistochemical labelings of marginal zone-specific Ags in spleen and of the same Ags in the lymph nodes (LN). Sections were stained with the anti-marginal zone macrophage mAb ERTR-9 (A, D, G) the anti-metallophilic macrophage mAb MOMA-1 (B, E, H), and the anti-MAdCAM mAb MECA-367 (C, F, I). Sections were from spleens of WT mice reconstituted with WT KLSC (AC), spleens of WT mice reconstituted with LT{alpha}-/- KLSC (DF), peripheral lymph nodes of WT mice reconstituted with LT{alpha}-/- KLSC (G, H), or mesenteric lymph node of WT mice reconstituted with LT{alpha}-/- KLSC (I). All sections were from mice at 23 wk after reconstitution, which are representative for all other time points studied.

 
Although the impact of the absence of MOMA-1+ and ERTR-9+ macrophages from the marginal zone on lymphocyte localization is unknown, it has been shown that fewer B cells enter the white pulp after elimination of marginal zone macrophages and marginal metallophilic macrophages (27). Furthermore, the significance of MAdCAM-1 expression on sinus lining cells in the marginal zone is unknown, since in blocking studies, MAdCAM-1 appeared not to regulate the entry of lymphocytes into the white pulp (28). Our results show that in the absence of macrophages and MAdCAM-1 expression in the marginal zone, B and T lymphocytes are still able to enter the white pulp. In addition, our results show that hemopoietically derived LT{alpha} controls expression of MAdCAM-1 and the presence of macrophages in the marginal zone of the spleen. T and B cells enter the spleen via the marginal sinus vessels, first attaching to the endothelial cells that line the marginal zone (opposite to the endothelial cells that overlie the white pulp), then migrating into the marginal zone, and then crossing into the white pulp (29). The lack of marginal zone-specific Ags does not seem to effect the ability of B and T lymphocytes to migrate to their own microenvironments within the white pulp.

LT{alpha}-/- B cells do not form primary follicles

Since formation of primary B cell follicles requires TNF-{alpha} (9), we were interested to see whether the primary B cell follicles were formed properly in mice reconstituted with LT{alpha}-/- KLSC. To analyze primary follicles in the spleens, lymph nodes, and Peyer’s patches, a double labeling with mAbs for IgM and IgD was performed. This allowed us to distinguish the B cells in the marginal zone from the B cells that form the follicles, since the IgM+IgD- B cells in the marginal zone are stained only for IgM (brown) while the B cells in the primary follicles express both IgD (blue) and IgM (brown) (Fig. 3Go). Mice reconstituted with WT KLSC had IgM+IgD- B cells properly located in the marginal zone, although the ring of B cells seemed thin at times, and primary follicles of dark IgM+IgD+ cells could be easily observed (Fig. 3GoA). However, when mice reconstituted with LT{alpha}-/- KLSC were analyzed, no IgM+IgD- cells could be observed in the marginal zone, and IgM+IgD+ cells did not organize in follicles, but formed ring-like structures around the T cells in the PALS (Fig. 3Go, B and C). Primary follicles were also absent from the lymph nodes and Peyer’s patches of mice reconstituted with LT{alpha}-/- cells but appeared normal in WT controls (data not shown).



View larger version (66K):
[in this window]
[in a new window]
 
FIGURE 3. Immunohistochemical labeling of splenic marginal zone and follicular B cells (AD) and donor-derived cells in mixed chimeras (E). Splenic sections from WT animal reconstituted with WT KLSC (A), LT{alpha}-/- KLSC (B, C), or mixed KLSC (D, E) are shown. Sections were stained for IgM (brown) and IgD (blue) (AD) or FDC-M2 (blue) and Ly-5.2 (brown) (E). In mice reconstituted with LT{alpha}-/- KLSC, IgD+IgM+ primary follicles could not be observed, while the IgM+IgD- cells were absent from the marginal zone (B). However, occasionally small IgM+IgD- GC (*) were observed in mice reconstituted with LT{alpha}-/- KLSC (C). GC could also be observed in WT animals reconstituted with either WT or mixed KLSC. In mixed chimeras, follicles were formed by cells derived from both WT and LT{alpha}-/- KLSC (E). In A a primary follicle is marked (arrow), and in E the marginal zone is marked (-). All sections were from mice at 27 wk after reconstitution, which are representative for all other time points studied.

 
In mixed chimeras, B cells derived from LT{alpha}-/- KLSC could be distinguished from B cells derived from WT KLSC by the expression of either Ly-5.1 or Ly-5.2, since all cells derived from LT{alpha}-/- KLSC express Ly-5.1 and all WT express Ly-5.2. We observed that primary follicles could readily be detected in mice reconstituted with mixed WT and LT{alpha}-/- KLSC and contained cells derived from both WT KLSC and LT{alpha}-/- KLSC (Fig. 3Go, D and E). This suggested that LT{alpha}-/- B cells are able to participate in the formation of primary follicles, as long as a signal derived from WT hemopoietic cells is present. Furthermore, LT{alpha}-/- B cells are not at a competitive disadvantage compared with WT B cells in follicular entry as similar numbers of each population were found in the follicles.

We also analyzed reconstituted animals for the presence of FDC in the B cell areas using the mAb FDC-M2. Although FDC were easily visible in spleens of mice reconstituted with WT KLSC at 13 wk after reconstitution, only a few FDC could be found in mesenteric lymph nodes, but not peripheral lymph nodes or spleen, of mice reconstituted with LT{alpha}-/- KLSC (see Fig. 4Go for spleen). Furthermore, by 27 wk postreconstitution, FDC networks were still present in mice reconstituted with WT KLSC (Fig. 4GoA); however, no FDC could be found in spleens of mice reconstituted with LT{alpha}-/- KLSC (Fig. 4GoB). The observation that FDC were detected in mesenteric lymph nodes of mice reconstituted with LT{alpha}-/- cells at 13 wk, but not at later time points, is suggestive of a model in which FDC are continuously renewed or whose survival depends on local LT{alpha}+ cells. Although some investigators propose that FDC are derived from locally present reticular cells (30, 31, 32), others have proposed that the precursors to FDC reside in the BM (33). Our data suggest that either the replacement or maintenance of existing FDC is dependent on LT{alpha} from a BM-derived cell type at some point during the differentiation pathway, although we cannot address whether the FDC themselves are BM or locally derived as FDC do not express Ly-5.



View larger version (118K):
[in this window]
[in a new window]
 
FIGURE 4. Immunohistochemical labeling of FDC in spleen. Sections were stained with mAb FDC-M2. Spleen sections of WT mice reconstituted with WT KLSC at 27 wk postreconstitution (A) or WT mice reconstituted with LT{alpha}-/- KLSC at 27 wk postreconstitution (B). No FDC networks could be observed in LT{alpha}-/- KLSC-reconstituted mice. Stainings are representative for all other time points studied.

 
LT{alpha}-/- B cells can form germinal centers

Analysis for the presence of GC by peanut agglutinin labeling showed obvious GC in the mesenteric lymph node as well as spleen and Peyer’s patches of mice reconstituted with WT KLSC. To our surprise, however, even some of the mice reconstituted with LT{alpha}-/- KLSC had well-defined peanut agglutinin+ GC (Fig. 3GoC; Fig. 5Go G and H). However, the GC found in mice reconstituted with LT{alpha}-/- KLSC were formed in the absence of detectable FDC (Fig. 5GoH). The ability of LT{alpha}-/- B cells to produce GC in the absence of FDC has been reported recently; however, these GC could be found only in LN and not in spleen (15). In our studies, we observed GC in the absence of FDC not only at 13 wk after reconstitution in both spleen and lymph nodes but also at 23 and 27 wk after reconstitution when FDC had been absent for several month. The peanut agglutinin+ GC in mice reconstituted with LT{alpha}-/- KLSC were smaller than GC from mice reconstituted with WT KLSC, suggesting that these GC could be slowly disappearing in the absence of FDC, although the existence of GC in the absence of FDC has also been observed in the LTß-/- mice as well (17).



View larger version (77K):
[in this window]
[in a new window]
 
FIGURE 5. Immunohistochemical labeling of germinal centers. Splenic sections of WT mice reconstituted with WT KLSC (A, C, E) or for WT mice reconstituted with mixed KLSC (B, D, F). Serial sections were stained for FDC-M2 (blue) in combination with Ly-5.1 (brown), showing the LT{alpha}-/- KLSC-derived cells brown among an FDC network (A, B); FDC-M2 (blue) and peanut agglutinin (PNA) (brown) showing GC and FDC simultaneously (C, D); and FDC-M2 (blue) in combination with Ly-5.2 (brown), showing all WT KLSC-derived cells in brown (E, F). GC can be found that are completely Ly-5.1 positive and Ly-5.2 negative and are thus of LT{alpha}-/- KLS cell origin. G and H were stained for FDC-M2 (brown) and PNA (blue) and show that peanut agglutinin (PNA) PNA+ GC can be observed in the absence of detectable FDC.

 
GC were present in the mixed chimeras as well (Fig. 3GoD). When examined for the expression of either Ly-5.1 or Ly-5.2, GC were found to be predominantly, although not exclusively, derived from either LT{alpha}-/- B cells (Ly-5.1) or WT B cells (Ly-5.2), suggesting that GC contain the progeny of a limited number of founding B cells (Fig. 3Go, D and E; Fig. 5Go, B, D, and F). Pauciclonality of GC has been suggested before (34, 35, 36, 37, 38, 39, 40, 41). Furthermore, B cells are not required to express their own LT{alpha} to participate in the germinal center reaction (Fig. 5Go, B, D, and F).

Summarizing our results we show that 1) LT{alpha} is involved in formation of primary B cell follicles; 2) LT{alpha}-/- B cells can form GC and that GC can exist in the absence of FDC; 3) B and T cell segregation does not require LT{alpha} expression on these cells or an intact marginal zone; 4) LT{alpha} expression in (a subset of) hemopoietic cells is required for a proper development of the marginal zone.

The characteristics observed in LT{alpha}-/- KLSC-reconstituted mice are similar to the specific defects seen in LTß-/- mice; i.e., GC formation without FDC, lack of normal splenic marginal zone, while lack of B T cell separation seems less severe in LTß-/- than in LT{alpha}-/- mice. Therefore, the abnormalities seen in both LTß-/- mice and WT mice reconstituted with LT{alpha}-/- KLSC could be due to lack of LT{alpha}1ß2 or LT{alpha}2ß1 on hemopoietic cells, while the defects unique to LT{alpha}-/- mice are caused by lack of LT{alpha}, independent of LTß, in nonhemopoietic cells.

Speculation

Perhaps the most striking finding in these experiments is the demonstration that the lymphoid organs of WT mice irradiated and reconstituted with KLSC from LT{alpha}-/- BM contain T and B cell domains, but that the B cell domains fail to aggregate Bµ{delta} cells around FDC, which are absent, to form classical primary follicles (12). Even more surprising, the lack of FDC and primary follicles do not block the ability of T/B/APC interactions that generate GC and Ab formation. In our experiments, these GC are IgM+IgD-, characteristic of GC in an immune response that has not undergone the IgH chain "class switch" (42). It is therefore reasonable to speculate that FDC do not play a role in the T/Bµ{delta}/APC interaction that leads to activated clones of B cells (43) to shed IgD (44, 45, 46) and L-selectin (47), enlarge, and form the first phase of a GC at the T-B domain interface (48). Rather, FDC and activated Th cells (that locate in the cortical zones of those GC (12, 49)) are required for other GC events, namely the IgH class switch (50), affinity maturation via selection of somatically mutated VH/VLs (39, 40, 51, 52, 53, 54), generation of class-switch memory B cells, and maturation of class switch plasma cells (55, 56, 57, 58, 59). The roles of Th vs. FDC in these events, if this is an accurate speculation, should be amenable to study. But how are FDC formed in a LT{alpha}-dependent fashion? In our view, cells expressing surface LT, such as the unusual population of CD4+CD3- (Ig0/0TCR0/0) lymphocytes that seed early lymphoid organs via their surface Peyer’s patch homing receptors (integrin {alpha}4ß7) (60, 61) are good candidates for the class of BM-derived cells that stimulate FDC maturation. FDC, once generated, form FDC networks that aggregate Bµ{delta} cells around them, perhaps via FDC MAdCAM-1 (62), interacting with {alpha}4ß7 on Bµ{delta} cells (63, 64, 65, 66, 67). These FDC-Bµ{delta} follicles can then receive Ig-Ag complexes for long term display of antigenic determinants, and only B cells with surface Ig of higher avidity than the Ig on FDC will compete successfully to receive FDC (and Th) signals via Ig receptors and costimulatory receptors, respectively, leading to the events of somatic mutation, IgH class switch, B memory, and Ab formation that characterizes this later phase of a B cell immune response. These events are summarized in Figure 6Go.



View larger version (15K):
[in this window]
[in a new window]
 
FIGURE 6. A model for LT{alpha} involvement in the maturation of FDC and for the role of FDC in the immune response. In this model, CD4+CD3- cells are required for FDC maturation. For the induction of class switch, affinity maturation, and formation of memory B cells, FDC, Th1, or Th2 and Ag-immunoglobulin complexes (Ag-Ig) are required, while FDC are not essential for the formation of IgM+ GC.

 


    Acknowledgments
 
We thank D. Chaplin for providing us with the LT{alpha}-/- mice and for critically reading the manuscript; L. van der Laan for supplying us with ED31; M. Kosco-Vilbois for the kind gift of mAb FDC-M2; G. Kraal for supplying us with MOMA-1 and ERTR-9 mAb; E. C. Butcher for the generous gift of MECA-367 hybridomas; and G. G. B. Klaus for the kind gift of mAb b.7.6 and 1.19.


    Footnotes
 
1 This work was supported by the Royal Netherlands Academy of Arts and Sciences (R.E.M.) and by National Cancer Institute Grant CA42551 (I.L.W.). T.D.R. was a recipient of a Helen Whitney fellowship during the course of this work. Back

2 These authors contributed equally to this work. Back

3 Address correspondence and reprint requests to Dr. Reina E. Mebius, Department of Cell Biology and Immunology, Faculty of Medicine, Vrije Universiteit, v.d. Boechorststraat 7, 1081 BT Amsterdam, The Netherlands. E-mail address: Back

4 Abbreviations used in this paper: LT, lymphotoxin; LTß-R, lymphotoxin-ß receptor; BM, bone marrow; KLSC, c-kit+Lin-Sca+ bone marrow cells; FDC, follicular dendritic cell(s); GC, germinal center(s); DC, dendritic cell; WT, wild type. Back

Received for publication February 2, 1998. Accepted for publication June 4, 1998.


    References
 Top
 Abstract
 Introduction
 Materials and Methods
 Results and Discussion
 References
 

  1. Vassalli, P.. 1992. The pathophysiology of tumor necrosis factors. Annu. Rev. Immunol. 10:411.[Medline]
  2. Jones, E. Y., D. I. Stuart, N. P. C. Walker. 1989. Structure of tumour necrosis factor. Nature 338:225.[Medline]
  3. Schoenfeld, H. J., B. Poeschl, J. R. Frey, H. Loetscher, W. Hunziker, A. Lustig, M. Zulauf. 1991. Efficient purification of recombinant human tumor necrosis factor ß from Escherichia coli yields a biologically active protein with a trimeric structure that binds to both tumor necrosis factor receptors. J. Biol. Chem. 266:3863.[Abstract/Free Full Text]
  4. Vandenabeele, P., W. Declerq, R. Beyaert, W. Fiers. 1995. Two tumour necrosis factor receptors: structure and function. Trends Cell Biol. 5:392.[Medline]
  5. Browning, J. L., A. Ngamek, P. Lawton, J. DeMarinis, R. Tizard, E. P. Chow, C. Hession, B. O’Brine-Greco, S. F. Foley, C. F. Ware. 1993. Lymphotoxin ß, a novel member of the TNF family that forms a heteromeric complex with lymphotoxin on the cell surface. Cell 72:847.[Medline]
  6. Crowe, P. D., T. L. VanArsdale, B. N. Walter, C. F. Ware, C. Hession, B. Ehrenfels, J. L. Browning, W. S. Din, R. G. Goodwin, C. A. Smith. 1994. A lymphotoxin-ß-specific receptor. Science 264:707.[Abstract/Free Full Text]
  7. Matsumoto, M., S. Mariathasan, M. H. Nahm, F. Baranyay, J. J. Peschon, D. D. Chaplin. 1996. Role of lymphotoxin and type I TNF receptor in the formation of germinal centers. Science 271:1289.[Abstract]
  8. LeHir, M., H. Bluethmann, M. H. Kosco-Vilbois, M. Müller, F. d. Padova, M. Moore, B. Ryffel, H.-P. Eugster. 1996. Differentiation of follicular dendritic cells and full antibody responses require tumor necrosis factor receptor-1 signaling. J. Exp. Med. 183:2367.[Abstract/Free Full Text]
  9. Pasparakis, M., L. Alexopoulou, V. Episkopou, G. Kollias. 1996. Immune and inflammatory responses in TNF{alpha}-deficient mice: a critical requirement for TNF{alpha} in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response. J. Exp. Med 184:1397.[Abstract/Free Full Text]
  10. Pasparakis, M., L. Alexopoulou, M. Grell, K. Pfizenmaier, H. Bluethmann, G. Kollias. 1997. Peyer’s patch organogenesis is intact yet formation of B lymphocyte follicles is defective in peripheral lymphoid organs of mice deficient for tumor necrosis factor and its 55 kDa receptor. Proc. Natl. Acad. Sci. USA 94:6319.[Abstract/Free Full Text]
  11. Grouard, G., I. Durand, L. Filgueira, J. Banchereau, Y. J. Liu. 1996. Dendritic cells capable of stimulating T cells in germinal centres. Nature 384:364.[Medline]
  12. Gutman, G. A., I. L. Weissman. 1972. Lymphoid tissue architecture: experimental analysis of the origin and distribution of T-cells and B-cells. Immunology 23:465.[Medline]
  13. DeTogni, P., J. Goellner, N. H. Ruddle, P. R. Streeter, A. Fick, S. Mariathasan, S. C. Smith, R. Carlson, L. P. Shornick, J. Strauss-Schoenberger, J. H. Russell, R. Karr, D. D. Chaplin. 1994. Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin. Science 264:703.[Abstract/Free Full Text]
  14. Banks, T. A., B. T. Rouse, M. K. Kerley, P. J. Blair, V. L. Godfrey, N. A. Kuklin, D. M. Bouley, J. Thomas, S. Kanangat, M. L. Mucenski. 1995. Lymphotoxin-{alpha}-deficient mice. J. Immunol. 155:1685.[Abstract]
  15. Fu, Y.-X., G. Huang, M. Matsumoto, H. Molina, D. D. Chaplin. 1997. Independent signals regulate development of primary and secondary follicle structure in spleen and mesenteric lymph node. Proc. Natl. Acad. Sci. USA 94:5739.[Abstract/Free Full Text]
  16. Rennert, P. D., J. L. Browning, R. Mebius, F. Mackay, P. S. Hochman. 1996. Surface lymphotoxin {alpha}/ß complex is required for the development of peripheral lymphoid organs. J. Exp. Med. 184:1999.[Abstract/Free Full Text]
  17. Koni, P. A., R. Sacca, P. Lawton, J. L. Browning, N. H. Ruddle, R. A. Flavell. 1997. Distinct roles in lymphoid organogenesis for lymphotoxins {alpha} and ß revealed in lymphotoxin ß-deficient mice. Immunity 6:491.[Medline]
  18. Fu, Y.-X., H. Molina, M. Matsumoto, G. Huang, J. Min, D. D. Chaplin. 1997. Lymphotoxin-{alpha} (LT-{alpha}) supports development of splenic follicular structure that is required for IgG responses. J. Exp. Med. 185:2111.[Abstract/Free Full Text]
  19. Van der Laan, L. J., M. Kangas, E. A. Döpp, E. Broug-Holub, O. Elomaa, K. Tryggvason, K. Kraal. 1997. Macrophage scavenger receptor MARCO: in vitro and in vivo regulation and involvement in the anti-bacterial host defense. Immunol. Lett. 57:203.[Medline]
  20. Julius, M. H., C. H. Heusser, K. Hartmann. 1984. Induction of resting B cells to DNA synthesis by soluble monoclonal anti-immunoglobulin. Eur. J. Immunol. 14:753.[Medline]
  21. Parry, S. L., M. J. Holman, J. Hasbold, G. G. B. Klaus. 1994. Plastic-immobilized anti-µ or anti-{delta} antibodies induce apoptosis in mature murine B lymphocytes. Eur. J. Immunol. 24:974.[Medline]
  22. Randall, T. D., F. E. Lund, M. C. Howard, I. L. Weissman. 1996. Expression of murine CD38 defines a population of long-term reconstituting hematopoietic stem cells. Blood 87:4057.[Abstract/Free Full Text]
  23. Claassen, E., L. T. Adler. 1988. Sequential double immunocytochemical staining for in situ identification of an auto-anti-allotype immune response in allotype suppressed rabbits. J. Histochem. Cytochem. 36:1455.[Abstract]
  24. Reichert, R., I. L. Weissman. 1984. Immunology Benjamin-Cumings, Menlo Park, CA.
  25. Mackay, F., G. R. Majeau, P. Lawton, P. S. Hochman, J. L. Browning. 1997. Lymphotoxin but not tumour necrosis factor functions to maintain splenic architecture and humoral responsiveness in adult mice. Eur. J. Immunol. 27:2033.[Medline]
  26. Eugster, H. P., M. Muller, U. Karrer, B. D. Car, B. Schnyder, V. M. Eng, G. Woerly, M. L. Hir, F. d. Padova, M. Aguet, R. Zinkernagel, H. Bleuthmann, B. Ryffel. 1996. Multiple immune abnormalities in tumor necrosis factor and lymphotoxin-{alpha} double deficient mice. Int. Immunol. 8:23.[Abstract/Free Full Text]
  27. Kraal, G., H. Rodrigues, K. Hoeben, N. Van Rooijen. 1989. Lymphocyte migration in the spleen: the effect of macrophage elimination. Immunology 68:227.[Medline]
  28. Kraal, G., K. Schornagel, P. R. Streeter, B. Holzman, E. C. Butcher. 1995. Expression of the mucosal vascular addressin, MAdCAM-1, on sinus-lining cells in the spleen. Am. J. Pathol. 147:763.[Abstract]
  29. Gutman, G. A., I. L. Weissman. 1973. Homing properties of thymus-independent follicular lymphocytes. Transplantation 16:621.[Medline]
  30. Rademakers, L. H., R. A. De Weger, P. J. Roholl. 1988. Identification of alkaline phosphatase positive cells in human germinal centres as follicular dendritic cells. Adv. Exp. Med. Biol. 237:165.[Medline]
  31. Heuserman, U., K. Zuborn, L. Schroeder, H. Sutte. 1980. The origin of the dendritic reticulum cell. Cell Tissue Res. 209:279.[Medline]
  32. Humphrey, J. H., D. Grennan, V. Sundaram. 1984. The origin of follicular dendritic cells in the mouse and the mechanism of trapping of immune complexes on them. Eur. J. Immunol. 14:859.[Medline]
  33. Szakal, A. K., Z. F. Kapasi, S. T. Haley, J. G. Tew. 1995. Multiple lines of evidence favoring a bone marrow derivation of follicular dendritic cells (FDC). Adv. Exp. Med. Biol. 378:267.[Medline]
  34. Razecca, K. J., E. Pillemer, I. L. Weissman, R. V. Rouse. 1986. In situ identification of idiotype-positive cells participating in the immune response to phosphorylcholine. Eur. J. Immunol. 16:393.[Medline]
  35. Lebecque, S., O. de Bouteiller, C. Arpin, J. Banchereau, Y. J. Liu. 1997. Germinal center founder cells display propensity for apoptosis before onset of somatic mutation. J. Exp. Med. 185:563.[Abstract/Free Full Text]
  36. Jacob, J., R. Kassir, G. Kelsoe. 1991. In situ studies of the primary immune response to (4-hydroxy-3-nitrophenyl)acetyl. I. The architecture and dynamics of responding cell populations. J. Exp. Med. 173:1165.[Abstract/Free Full Text]
  37. Jacob, J., G. Kelsoe. 1992. In situ studies of the primary immune response to (4-hydroxy-3-nitrophenyl) acetyl. II. A common clonal origin for periarteriolar lymphoid sheath-associated foci and germinal centers. J. Exp. Med. 176:679.[Abstract/Free Full Text]
  38. Liu, Y.-J., J. Zhang, P. J. Lane, E. Y.-T. Chan, I. C. MacLennan. 1991. Sites of specific B cell activation in primary and secondary responses to T cell-dependent and T cell-independent antigens. Eur. J. Immunol. 21:2951.[Medline]
  39. Küppers, R. M., M. L. Zhao, K. Hansmann, K. Rajewsky. 1993. Tracing B-cell development in human germinal-centers by molecular analysis of single cells picked from histological sections. EMBO 12:4955.[Medline]
  40. Jacob, J., G. Kelsoe, K. Rajewsky, U. Weiss. 1991. Intraclonal generation of antibody mutants in germinal centres. Nature 354:389.[Medline]
  41. Kroese, F. G. M., A. S. Wubbema, H. G. Seijnen, P. Nieuwenhuis. 1987. Germinal centers develop oligoclonally. Eur. J. Immunol. 17:1069.[Medline]
  42. Liu, Y.-J., C. Arpin. 1997. Germinal center development. Immunol. Rev. 156:111.[Medline]
  43. Gray, D.. 1988. Recruitment of virgin B cells into an immune response is restricted to activation outside lymphoid follicles. Immunology 65:73.[Medline]
  44. Martin, L. N., G. A. Leslie. 1977. Lymphocyte surface IgD and IgM in Macaca monkeys: ontogeny, tissue distribution and occurrence on individual lymphocytes. Immunology 33:865.[Medline]
  45. Stein, H., A. Bonk, G. Tolksdorf, K. Lennert, H. Rodt, J. Gerdes. 1980. Immunohistologic analysis of the organization of normal lymphoid tissue and non-Hodgkin’s lymphomas. J. Histochem. Cytochem. 28:746.[Abstract]
  46. Butcher, E. C., R. V. Rouse, R. L. Coffman, C. N. Nottenburg, R. R. Hardy, I. L. Weissman. 1982. Surface phenotype of Peyer’s patch germinal center cells: implications for the role of germinal centers in B cell differentiation. J. Immunol. 129:2698.[Abstract]
  47. Reichert, R. A., W. M. Gallatin, I. L. Weissman, E. C. Butcher. 1983. Germinal center B cells lack homing receptors necessary for normal lymphocyte recirculation. J. Exp. Med. 157:813.[Abstract/Free Full Text]
  48. Kelsoe, G.. 1995. In situ studies of the germinal center reaction. Adv. Immunol. 60:267.[Medline]
  49. Zheng, B., W. Xue, G. Kelsoe. 1994. Locus-specific somatic hypermutation in germinal centre T cells. Nature 372:556.[Medline]
  50. Liu, Y.-J., F. Malisan, O. de Bouteiller, C. Guret, S. Lebecque, J. Banchereau, F. C. Mills, E. E. Max, H. Martinez-Valdez. 1996. Within germinal centers, isotype switching of immunoglobulin genes occurs after the onset of somatic mutation. Immunity 4:241.[Medline]
  51. Pascual, V., Y.-J. Liu, A. Maglaski, O. d. Bouteiller, J. Banchereau, J. D. Capra. 1994. Analysis of somatic mutation in five B cell subsets in human tonsil. J. Exp. Med. 180:329.[Abstract/Free Full Text]
  52. Berek, C., A. Berger, M. Apel. 1991. Maturation of the immune response in germinal centers. Cell 67:1121.[Medline]
  53. Leanderson, T., E. Källberg, D. Gray. 1992. Expansion, selection and mutation of antigenic-specific B cells in germinal centers. Immunol. Rev. 126:47.[Medline]
  54. McHeyzer-Williams, M. G., M. J. MacLennan, P. A. Labor, G. J. V. Nossal. 1993. Antigen-driven B-cell differentiation in vivo. J. Exp. Med. 178:295.[Abstract/Free Full Text]
  55. Kraal, G., I. L. Weissman, E. C. Butcher. 1982. Germinal centre B cells: antigen specificity and changes in heavy chain class expression. Nature 298:377.[Medline]
  56. Klaus, G. G. B., J. H. Humphrey, A. Kunkl, D. W. Dongworth. 1980. The follicular dendritic cell: its role in antigen presentation in the generation of immunological memory. Immunol. Rev. 53:3.[Medline]
  57. Kosco-Vilbois, M. H., G. F. Burton, Z. F. Kapasi, A. K. Szakal, J. G. Tew. 1989. Antibody-forming cell induction during an early phase of germinal centre development and its delay with ageing. Immunology 68:312.[Medline]
  58. Coico, R. F., B. S. Bhogal, G. J. Thorbecke. 1983. Relationship of germinal centers in lymphoid tissue to immunologic memory. IV. Transfer of B cell memory with lymph node cells fractionated according to their receptors for peanut agglutinin. J. Immunol. 131:2254.[Abstract]
  59. Arpin, C., J. Dechanet, C. Van Kooten, P. Merville, G. Grouard, F. Briere, J. Banchereau, Y.-J. Liu. 1995. Generation of memory B cells and plasma cells in vitro. Science 268:720.[Abstract/Free Full Text]
  60. Mebius, R. E., P. R. Streeter, S. Michie, E. C. Butcher, I. L. Weissman. 1996. A developmental switch in lymphocyte homing receptor and endothelial vascular addressin expression regulates lymphocyte homing and permits CD4+ CD3- cells to colonize lymph nodes. Proc. Natl. Acad. Sci. USA 93:11019.[Abstract/Free Full Text]
  61. Mebius, R. E., P. Rennert, I. L. Weissman. 1997. Developing lymph nodes collect CD4+ CD3-LTB+ cells that can differentiate to APC, NK cells, and follicular cells, but not T- or B-cells. Immunity. 7:493.[Medline]
  62. Szabo, M. C., E. C. Butcher, L. M. McEnvoy. 1997. Specialization of mucosal follicular dendritic cells revealed by mocosal addressin-cell adhesion molecule-1 display. J. Immunol. 158:5584.[Abstract]
  63. Berlin, C., E. L. Berg, M. J. Briskin, D. P. Andrew, P. J. Kilshaw, B. Holzmann, I. L. Weissman, A. Hamann, E. C. Butcher. 1993. {alpha}4ß7 integrin mediates lymphocyte binding to the mucosal vascular addressin MAdCAM-1. Cell 74:185.[Medline]
  64. Hamann, A., D. P. Andrew, D. Jablonski-Westrich, B. Holzmann, E. C. Butcher. 1994. Role of {alpha}4-integrins in lymphocyte homing to mucosal tissues in vivo. J. Immunol. 152:3282.[Abstract]
  65. Holzmann, B., B. W. McIntyre, I. L. Weissman. 1989. Identification of a murine Peyer’s patch-specific lymphocyte homing receptor as an integrin with a chain homologous to human VLA-4. Cell 56:37.[Medline]
  66. Holzmann, B., I. L. Weissman. 1989. Peyer’s patch-specific lymphocyte homing receptors consist of a VLA-4-like {alpha} chain associated with either of two integrin ß chains, one of which is novel. EMBO J. 8:1735.[Medline]
  67. Hu, M. C.-T., D. T. Crowe, I. L. Weissman, B. Holzmann. 1992. Cloning and expression of mouse integrin ßp7): a functional role in Peyer’s patch-specific homing. Proc. Natl. Acad. Sci. USA 89:8254.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
BloodHome page
T. Murakami, X. Chen, K. Hase, A. Sakamoto, C. Nishigaki, and H. Ohno
Splenic CD19 CD35+B220+ cells function as an inducer of follicular dendritic cell network formation
Blood, August 15, 2007; 110(4): 1215 - 1224.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Louten, N. van Rooijen, and C. A. Biron
Type 1 IFN Deficiency in the Absence of Normal Splenic Architecture during Lymphocytic Choriomeningitis Virus Infection.
J. Immunol., September 1, 2006; 177(5): 3266 - 3272.
[Abstract] [Full Text] [PDF]


Home page
Mayo Clin Proc.Home page
R. H. Carter
B Cells in Health and Disease
Mayo Clin. Proc., March 1, 2006; 81(3): 377 - 384.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. Wen, S. A. Shinton, R. R. Hardy, and K. Hayakawa
Association of B-1 B Cells with Follicular Dendritic Cells in Spleen
J. Immunol., June 1, 2005; 174(11): 6918 - 6926.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
A. Soriano-Izquierdo, M. Gironella, A. Massaguer, F. E. B. May, A. Salas, M. Sans, R. Poulsom, L. Thim, J. M. Pique, and J. Panes
Trefoil peptide TFF2 treatment reduces VCAM-1 expression and leukocyte recruitment in experimental intestinal inflammation
J. Leukoc. Biol., February 1, 2004; 75(2): 214 - 223.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
T. Samardzic, D. Marinkovic, P. J. Nielsen, L. Nitschke, and T. Wirth
BOB.1/OBF.1 Deficiency Affects Marginal-Zone B-Cell Compartment
Mol. Cell. Biol., December 1, 2002; 22(23): 8320 - 8331.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
T. T. Lu and J. G. Cyster
Integrin-Mediated Long-Term B Cell Retention in the Splenic Marginal Zone
Science, July 19, 2002; 297(5580): 409 - 412.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
E. Alcamo, N. Hacohen, L. C. Schulte, P. D. Rennert, R. O. Hynes, and D. Baltimore
Requirement for the NF-{kappa}B Family Member RelA in the Development of Secondary Lymphoid Organs
J. Exp. Med., January 22, 2002; 195(2): 233 - 244.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. T. Crowley, C. R. Reilly, and D. Lo
Influence of Lymphocytes on the Presence and Organization of Dendritic Cell Subsets in the Spleen
J. Immunol., November 1, 1999; 163(9): 4894 - 4900.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mebius, R. E.
Right arrow Articles by Randall, T. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mebius, R. E.
Right arrow Articles by Randall, T. D.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS